These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11332995)

  • 1. Bridging the gap in San Francisco: the process of integrating harm reduction and traditional substance abuse services.
    Gleghorn A; Rosenbaum M; Garcia BA
    J Psychoactive Drugs; 2001; 33(1):1-7. PubMed ID: 11332995
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrating harm reduction therapy and traditional substance abuse treatment.
    Marlatt GA; Blume AW; Parks GA
    J Psychoactive Drugs; 2001; 33(1):13-21. PubMed ID: 11332996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opening inspiration for "Bridging the gap: integrating traditional substance abuse and harm reduction services" (May 3-4, 1999, San Francisco).
    Sanders EC
    J Psychoactive Drugs; 2001; 33(1):9-12. PubMed ID: 11333006
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug abuse treatment on demand in San Francisco: preliminary findings.
    Guydish J; Moore L; Gleghorn A; Davis T; Sears C; Harcourt J
    J Psychoactive Drugs; 2000; 32(4):363-70. PubMed ID: 11210197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The war on addiction.
    Alter J
    Newsweek; 2001 Feb; 137(7):36-9. PubMed ID: 11246719
    [No Abstract]   [Full Text] [Related]  

  • 6. Severely and persistently mentally ill substance abusers: clinical and policy issues.
    Zweben JE
    J Psychoactive Drugs; 2000; 32(4):383-9. PubMed ID: 11210200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Holistic Native network: integrated HIV/AIDS, substance abuse, and mental health services for Native Americans in San Francisco.
    Nebelkopf E; Penagos M
    J Psychoactive Drugs; 2005 Sep; 37(3):257-64. PubMed ID: 16295008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social policy issues in narcotics abuse.
    Schmolling P
    J Health Soc Policy; 1993; 5(2):49-65. PubMed ID: 10171762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for implementation of harm reduction in treatment settings.
    Denning P
    J Psychoactive Drugs; 2001; 33(1):23-6. PubMed ID: 11332997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practitioners' attitudes concerning evidence-based guidelines in Belgian substance abuse treatment.
    Autrique M; Vanderplasschen W; Broekaert E; Sabbe B
    Eur Addict Res; 2009; 15(1):47-55. PubMed ID: 19052462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A field-based dissemination component in a drug abuse research center.
    Sorensen JL; Clark WW
    NIDA Res Monogr; 1995; 155():186-97. PubMed ID: 8594456
    [No Abstract]   [Full Text] [Related]  

  • 12. Response on drug policy.
    McDonough JR
    Public Health Rep; 1999; 114(2):99-100. PubMed ID: 10199704
    [No Abstract]   [Full Text] [Related]  

  • 13. The San Francisco centralized intake unit: a description of participants and service episodes.
    Woods WJ; Klingemann SD; Guydish JR
    J Psychoactive Drugs; 2002; 34(1):17-24. PubMed ID: 12003109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to drug abuse treatment under Treatment on Demand policy in San Francisco.
    Sorensen JL; Guydish J; Zilavy P; Davis TB; Gleghorn A; Jacoby M; Sears C
    Am J Drug Alcohol Abuse; 2007; 33(2):227-36. PubMed ID: 17497545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origins of commitment for substance abuse in the United States.
    Hall KT; Appelbaum PS
    J Am Acad Psychiatry Law; 2002; 30(1):33-45; discussion 46-8. PubMed ID: 11931367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new paradigm for long-term recovery.
    DuPont RL; Humphreys K
    Subst Abus; 2011 Jan; 32(1):1-6. PubMed ID: 21302178
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes In US spending on Mental Health And Substance Abuse Treatment, 1986-2005, and implications for policy.
    Mark TL; Levit KR; Vandivort-Warren R; Buck JA; Coffey RM
    Health Aff (Millwood); 2011 Feb; 30(2):284-92. PubMed ID: 21289350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Walden House young adult HIV program.
    Greenberg B; Morris A; Nguyen H
    Psychiatr Serv; 2001 Jul; 52(7):973. PubMed ID: 11433120
    [No Abstract]   [Full Text] [Related]  

  • 19. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCCSAPR: a new approach to drug policy research in the twenty-first century. California Collaborative Center for Substance Abuse Policy Research.
    Smith DE; Seymour RB
    J Psychoactive Drugs; 2000; 32(4):359-61. PubMed ID: 11210196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.